HBM Holdings Limited (2142 HK)

Analysis

Health Care • China

Engages in research and development of therapeutics in the fields of immuno-oncology and immunology diseases

Refresh

Company Presentation • 30 Aug 2021 12:30

Company Presentation • 24 Mar 2022 12:30

Company Presentation • 29 Mar 2021 12:30

Company Presentation • 30 Mar 2026 21:50

Company Presentation • 31 Mar 2025 16:00